Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

172.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 248.00p
  • 52 Week Low: 147.50p
  • Currency: UK Pounds
  • Shares Issued: 44.96m
  • Volume: 8,500
  • Market Cap: 77.56m
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-18 Interim 25.34 (2.85) (6.60)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 53.69 (1.50) (3.18)p n/a n/a n/a n/a 0.0%
31-Dec-19 60.08 4.92 9.09p 19.0 n/a n/a n/a 0.0%
31-Dec-20 67.07 6.99 12.23p 14.1 0.4 +34% n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 43.69 17.84 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Ergomed Market Data

Currency UK Pounds
Share Price 172.50p
Change Today -2.50p
% Change -1.43 %
52 Week High 248.00p
52 Week Low 147.50p
Volume 8,500
Shares Issued 44.96m
Market Cap 77.56m
Beta 0.00

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.2% below the market average26.2% below the market average26.2% below the market average26.2% below the market average26.2% below the market average
5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average
Price Trend
12.69% above the market average12.69% above the market average12.69% above the market average12.69% above the market average12.69% above the market average
49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average
Income Not Available
Growth
32.97% above the market average32.97% above the market average32.97% above the market average32.97% above the market average32.97% above the market average
10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 18-Jan-2019

Time Volume / Share Price
16:24 10,000 @ 170.00p
16:24 15,263 @ 167.50p
16:26 2,500 @ 170.00p
16:24 2,500 @ 170.00p
10:58 3,500 @ 170.50p

Ergomed Key Personnel

Chair Peter George
CEO Stephen Stamp
COO Jan Petracek
CFO Stuart Jackson

Top of Page